Modified Citrus Pectin Activates Immune Cells Against Leukemia
Author Information
Author(s): Ramachandran Cheppail, Wilk Barry J, Hotchkiss Arland, Chau Hoa, Eliaz Isaac, Melnick Steven J
Primary Institution: Dharma Biomedical LLC
Hypothesis
Can modified citrus pectin (MCP) activate human blood lymphocyte subsets and enhance their activity against leukemia cells?
Conclusion
Modified citrus pectin has immunostimulatory properties that activate functional NK cells against K562 leukemic cells.
Supporting Evidence
- MCP activated T-cytotoxic cells and B-cells in a dose-dependent manner.
- MCP-activated NK-cells demonstrated functionality in inducing cancer cell death.
- MCP showed significant activation of NK-cells at higher concentrations.
Takeaway
This study shows that a substance called modified citrus pectin can help our immune cells fight leukemia by making them more active.
Methodology
Human blood samples were treated with modified citrus pectin and analyzed for lymphocyte activation using flow cytometry.
Potential Biases
Potential bias due to authors' affiliations with the manufacturer of MCP.
Limitations
The study was conducted in vitro with a small sample size and lacks in vivo data.
Participant Demographics
Three unidentified healthy volunteers provided blood samples.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website